196 related articles for article (PubMed ID: 9849696)
21. Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens.
Bleyzac N; Souillet G; Magron P; Janoly A; Martin P; Bertrand Y; Galambrun C; Dai Q; Maire P; Jelliffe RW; Aulagner G
Bone Marrow Transplant; 2001 Oct; 28(8):743-51. PubMed ID: 11781625
[TBL] [Abstract][Full Text] [Related]
22. The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy and therapy-related toxicity.
Hassan M; Ljungman P; Ringdén O; Hassan Z; Oberg G; Nilsson C; Békassy A; Bielenstein M; Abdel-Rehim M; Georén S; Astner L
Bone Marrow Transplant; 2000 May; 25(9):915-24. PubMed ID: 10800057
[TBL] [Abstract][Full Text] [Related]
23. Renal function after autologous bone marrow transplantation in children: a long-term prospective study.
Frisk P; Bratteby LE; Carlson K; Lönnerholm G
Bone Marrow Transplant; 2002 Jan; 29(2):129-36. PubMed ID: 11850707
[TBL] [Abstract][Full Text] [Related]
24. Bone marrow transplantation from matched related donors for patients with Fanconi anemia using low-dose busulfan and cyclophosphamide as conditioning.
Torjemane L; Ladeb S; Ben Othman T; Abdelkefi A; Lakhal A; Ben Abdeladhim A
Pediatr Blood Cancer; 2006 Apr; 46(4):496-500. PubMed ID: 16333862
[TBL] [Abstract][Full Text] [Related]
25. Subnormal androgen levels in young female bone marrow transplant recipients with ovarian dysfunction, chronic GVHD and receiving glucocorticoid therapy.
Hovi L; Saarinen-Pihkala UM; Taskinen M; Wikström AM; Dunkel L
Bone Marrow Transplant; 2004 Mar; 33(5):503-8. PubMed ID: 14716348
[TBL] [Abstract][Full Text] [Related]
26. [Endocrinal sequela in bone marrow transplantations during childhood and adolescence].
Le Heup B; von Bueltzingloewen A; Bordigoni P; Sommelet D; Pierson M
Ann Pediatr (Paris); 1993 Sep; 40(7):463-8. PubMed ID: 8239398
[TBL] [Abstract][Full Text] [Related]
27. Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment?
Léger J; Reynaud R; Czernichow P
J Pediatr; 2000 Dec; 137(6):819-25. PubMed ID: 11113839
[TBL] [Abstract][Full Text] [Related]
28. Allograft of ovarian cortex between two genetically non-identical sisters: case report.
Donnez J; Dolmans MM; Pirard C; Van Langendonckt A; Demylle D; Jadoul P; Squifflet J
Hum Reprod; 2007 Oct; 22(10):2653-9. PubMed ID: 17670763
[TBL] [Abstract][Full Text] [Related]
29. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
Kröger N; Zabelina T; Sonnenberg S; Krüger W; Renges H; Stute N; Finkenstein F; Mayer U; Holstein K; Fiedler W; Colberg H; Sonnen R; Kuse R; Braumann D; Metzner B; del Valle F; Erttmann R; Kabisch H; Zander AR
Bone Marrow Transplant; 2000 Oct; 26(7):711-6. PubMed ID: 11042650
[TBL] [Abstract][Full Text] [Related]
30. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
[TBL] [Abstract][Full Text] [Related]
31. Fertility, pregnancies and offspring complications after bone marrow transplantation.
Hinterberger-Fischer M; Kier P; Kalhs P; Marosi C; Geissler K; Schwarzinger I; Pabinger I; Huber J; Spona J; Kolbabek H
Bone Marrow Transplant; 1991 Jan; 7(1):5-9. PubMed ID: 1904290
[TBL] [Abstract][Full Text] [Related]
32. Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission - long-term follow-up.
Vaidya SJ; Atra A; Bahl S; Pinkerton CR; Calvagna V; Horton C; Milan S; Shepherd V; Brain C; Treleaven J; Powles R; Tait D; Meller ST
Bone Marrow Transplant; 2000 Mar; 25(6):599-603. PubMed ID: 10734293
[TBL] [Abstract][Full Text] [Related]
33. Intensified conditioning regimen in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.
Kröger N; Krüger W; Wacker-Backhaus G; Hegewisch-Becker S; Stockschläder M; Fuchs N; Rüssmann B; Renges H; Dürken M; Bielack S; de Wit M; Schuch G; Bartels H; Braumann D; Kuse R; Kabisch H; Erttmann R; Zander AR
Bone Marrow Transplant; 1998 Dec; 22(11):1029-33. PubMed ID: 9877263
[TBL] [Abstract][Full Text] [Related]
34. Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphoma.
Hänel M; Kröger N; Sonnenberg S; Bornhäuser M; Krüger W; Kroschinsky F; Hänel A; Metzner B; Birkmann J; Schmid B; Hoffknecht MM; Fiedler F; Ehninger G; Zander AR
Ann Hematol; 2002 Feb; 81(2):96-102. PubMed ID: 11907790
[TBL] [Abstract][Full Text] [Related]
35. [Pregnancy in a patient with premature ovarian failure secondary to chemotherapy].
Triantafilo Y; Arteaga E; Duque G; Fernández C; Grebe G
Rev Med Chil; 1991 Jan; 119(1):60-3. PubMed ID: 1824146
[TBL] [Abstract][Full Text] [Related]
36. High-dose melphalan with autologous hematopoietic stem cell transplantation for acute myeloid leukemia: results of a retrospective analysis of the Italian Pediatric Group for Bone Marrow Transplantation.
Cesaro S; Meloni G; Messina C; Pillon M; Proglia A; Lanino E; Caniggia M; Bagnulo S; Pession A; Locatelli F;
Bone Marrow Transplant; 2001 Jul; 28(2):131-6. PubMed ID: 11509930
[TBL] [Abstract][Full Text] [Related]
37. Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients.
Carreras E; Rosiñol L; Terol MJ; Alegre A; de Arriba F; García-Laraña J; Bello JL; García R; León A; Martínez R; Peñarrubia MJ; Poderós C; Ribas P; Ribera JM; San Miguel J; Bladé J; Lahuerta JJ;
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1448-54. PubMed ID: 18022574
[TBL] [Abstract][Full Text] [Related]
38. Prevention of gonadal toxicity and preservation of gonadal function and fertility in young women with systemic lupus erythematosus treated by cyclophosphamide: the PREGO-Study.
Manger K; Wildt L; Kalden JR; Manger B
Autoimmun Rev; 2006 Apr; 5(4):269-72. PubMed ID: 16697968
[TBL] [Abstract][Full Text] [Related]
39. Children with sickle cell disease: growth and gonadal function after hematopoietic stem cell transplantation.
Brachet C; Heinrichs C; Tenoutasse S; Devalck C; Azzi N; Ferster A
J Pediatr Hematol Oncol; 2007 Jul; 29(7):445-50. PubMed ID: 17609621
[TBL] [Abstract][Full Text] [Related]
40. Gonadal function in adolescents receiving different conditioning regimens for bone marrow transplantation.
Giorgiani G; Bozzola M; Cisternino M; Locatelli F; Gambarana D; Bonetti F; Zecca M; Lorini R; Severi F
Bone Marrow Transplant; 1991; 8 Suppl 1():53. PubMed ID: 1760641
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
